Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the incidence and evolution over-time of co-morbidities in a general dual-chamber pacemaker population (n=2188 patients) through a 2 years follow-up.


Clinical Trial Description

The study will focus on the number of patients moving to persistent Atrial Fibrillation as a function of cumulative %Vp (< or >40%), in a general dual-chamber pacemaker population through a 2 year follow-up (n=2188).

The same endpoint will be analyzed in sub populations (Sinus Node Disease and AVB) at 4 years follow up (n=4290). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01188356
Study type Observational
Source MicroPort CRM
Contact
Status Completed
Phase
Start date March 2010
Completion date August 31, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT02245009 - Safety of External Electrocardioversion in Device Patients N/A
Completed NCT02241382 - Cologne Cardioversion Study N/A
Completed NCT01439386 - Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter Phase 3
Not yet recruiting NCT06293430 - Registry on Luma Vision's VERAFEYE System (ENLIgHT)
Recruiting NCT03209583 - ATrial Tachycardia PAcing Therapy in Congenital Heart
Recruiting NCT06083012 - Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation
Recruiting NCT05883631 - RESOLVE-AF: Clinical Evaluation of the Ablacathâ„¢ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. N/A
Recruiting NCT05434650 - Abbott Atrial Fibrillation Post Approval Study
Recruiting NCT05014802 - Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Completed NCT05113056 - AcQForce Pulsed Field Ablation-CE N/A
Completed NCT05362656 - AutoMatic disPERsion Tagging Function Preliminary Evaluation N/A
Recruiting NCT05411614 - Hybrid AbLaTion of Atrial Fibrillation N/A
Active, not recruiting NCT05213104 - Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia Phase 3
Active, not recruiting NCT03053843 - Mediterranean Diet Plus Extravirgin Olive Oil in the Prevention of Recurrent Arrhythmias. The PREDIMAR (PREvención Con DIeta Mediterránea de Arritmias Recurrentes) Trial N/A
Recruiting NCT03458273 - Real Zero Fluoroscopy Catheter Ablation.
Completed NCT04394923 - Relationship Between the Posterior Atrial Wall and the Esophagus: Esophageal Position and Temperature MEasurement During Atrial Fibrillation Ablation. N/A
Completed NCT02106663 - Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation N/A
Completed NCT03854149 - Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study
Recruiting NCT05488470 - QT Changes as Detected From LINQ ECG During and After Antiarrhythmic Loading (LINQ QT)
Completed NCT04579159 - The Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study (Smart in OAC - AFNET 9) N/A